Konstantinos Christofyllakis

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

Viola Poeschel, Gerhard Held, Marita Ziepert et al. · The Lancet · 2019 · 244 citations · Full text

Radiotherapy to bulky disease PET-negative after immunochemotherapy in elderly DLBCL patients: Results of a planned interim analysis of the first 187 patients with bulky disease treated in the OPTIMAL>60 study of the DSHNHL.

Michael Pfreundschuh, Konstantinos Christofyllakis, Bettina Altmann et al. · Journal of Clinical Oncology · 2017 · 36 citations

Pathology, Ricover-60 Bulk Pts, Pharmacotherapy +22

Excellent Outcome of Young Patients (18-60 years) with Favourable-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 4 Cycles CHOP Plus 6 Applications of Rituximab: Results of the 592 Patients of the Flyer Trial of the Dshnhl/GLA

Viola Poeschel, Gerhard Held, Marita Ziepert et al. · Blood · 2018 · 15 citations

Increased B‐cell activity with consumption of activated monocytes in severe COVID‐19 patients

Igor Age Kos, Benedikt Balensiefer, Vadim Lesan et al. · European Journal of Immunology · 2021 · 14 citations · Full text

Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial

Gerhard Held, Lorenz Thurner, Viola Poeschel et al. · HemaSphere · 2023 · 14 citations · Full text